This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Relationship: 1313
Title
Goblet cell metaplasia leads to Increase, Mucin production
Upstream event
Downstream event
AOPs Referencing Relationship
Taxonomic Applicability
| Term | Scientific Term | Evidence | Link |
|---|---|---|---|
| human | Homo sapiens | Moderate | NCBI |
Sex Applicability
| Sex | Evidence |
|---|---|
| Mixed | Low |
Life Stage Applicability
| Term | Evidence |
|---|---|
| Adults | Moderate |
Chronic mucus hypersecretion is a main feature of chronic lung diseases, and the presence of goblet cell hyperplasia or goblet cell metaplasia in the lungs of chronic obstructive pulmonary disease, asthma and cystic fibrosis patients has been inferred as cause for sustained mucus production (Rose and Voynow, 2006; Munkholm and Mortensen, 2014).
| ID | Experimental Design | Species | Upstream Observation | Downstream Observation | Citation (first author, year) | Notes |
|---|
| Title | First Author | Biological Plausibility |
Dose Concordance |
Temporal Concordance |
Incidence Concordance |
|---|
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
In some cases, it appears that the authors use the terms "goblet cell hyperplasia" and "goblet cell metaplasia" interchangeably, making the evaluation of the available evidence difficult. Because goblet cell metaplasia is also a feature of epithelial cell remodeling in the context of wound healing, its appearance can be transient. At least one study indicates that goblet cell hyperplasia is also found in healthy non-smokers (never- and former smokers), where it appears as isolated foci—as opposed to the more extensive involvement of the airway epithelium seen in e.g. COPD patients (Polosukhin et al., 2011).
Unknown
Our quantitative understanding of this KER is limited by the fact that few studies interrogate causality between goblet cell metaplasia and increased mucin production. To our knoweldge, there is no comprehensive, systematic study of the dose-response relationship. This may be primarily due to the fact that goblet cell hyperplasia is a qualitative finding on histopathological examination and cannot be as easily quantified as, for example, the number of cells that stain with an anti-MUC5AC antibody as a marker for mucin production.
Response-response Relationship
Time-scale
Known Feedforward/Feedback loops influencing this KER
Unknown